These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1328975)

  • 1. Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases.
    Barakat RR; Rubin SC; Wong G; Saigo PE; Markman M; Hoskins WJ
    Obstet Gynecol; 1992 Oct; 80(4):660-4. PubMed ID: 1328975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J; Yang W; Wu X
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed mesodermal tumors of the ovary: a clinicopathologic study of 14 cases.
    Dinh TV; Slavin RE; Bhagavan BS; Hannigan EV; Tiamson EM; Yandell RB
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):409-12. PubMed ID: 2841630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant mixed mesodermal tumors of the ovary: a clinical analysis of 12 cases].
    Li H; Shi S; Zhang W
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):460-2. PubMed ID: 10920946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
    Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
    Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
    Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
    Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mixed mesodermal tumor of the ovary: a report of 22 cases.
    Dictor M
    Obstet Gynecol; 1985 May; 65(5):720-4. PubMed ID: 2984621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.
    Le T; Krepart GV; Lotocki RJ; Heywood MS
    Gynecol Oncol; 1997 May; 65(2):237-40. PubMed ID: 9159331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery for stage IV epithelial ovarian cancer.
    Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
    J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinosarcoma of the ovary-a case series.
    Rutledge TL; Gold MA; McMeekin DS; Huh WK; Powell MA; Lewin SN; Mutch DG; Johnson GA; Walker JL; Mannel RS
    Gynecol Oncol; 2006 Jan; 100(1):128-32. PubMed ID: 16213011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.
    Akahira JI; Yoshikawa H; Shimizu Y; Tsunematsu R; Hirakawa T; Kuramoto H; Shiromizu K; Kuzuya K; Kamura T; Kikuchi Y; Kodama S; Yamamoto K; Sato S
    Gynecol Oncol; 2001 Jun; 81(3):398-403. PubMed ID: 11371128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
    Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
    Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and prognostic factors in ovarian germ cell malignancies.
    Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
    Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and prognosis of epithelial ovarian cancer: five year multi-center study.
    Khodabakhshi R; Yahyazadeh-Jabbari SH; Gohari MR; Shahidi J; Ameri A
    Saudi Med J; 2008 Dec; 29(12):1735-8. PubMed ID: 19082223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.